GT Biopharma Inc GTBP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/20/22 EDT
2.66quote price arrow down-0.01 (-0.37%)
Volume
854
Close
2.67quote price arrow up+0.01 (+0.38%)
Volume
139,583
52 week range
1.51 - 19.73
Loading...
  • Open2.70
  • Day High2.70
  • Day Low2.51
  • Prev Close2.66
  • 52 Week High19.73
  • 52 Week High Date06/14/21
  • 52 Week Low1.51
  • 52 Week Low Date05/06/22

Key Stats

  • Market Cap81.44M
  • Shares Out30.50M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change-12.46

KEY STATS

  • Open2.70
  • Day High2.70
  • Day Low2.51
  • Prev Close2.66
  • 52 Week High19.73
  • 52 Week High Date06/14/21
  • 52 Week Low1.51
  • 52 Week Low Date05/06/22
  • Market Cap81.44M
  • Shares Out30.50M
  • 10 Day Average Volume0.21M
  • Dividend-
  • Dividend Yield-
  • Beta0.45
  • YTD % Change-12.46

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-2.65
  • Fwd P/E (NTM)-3.31
  • EBITDA (TTM)-33.955M
  • ROE (TTM)-160.94%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GT Biopharma Inc

There is no recent news for this security.

Profile

MORE
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The Company's TriKE platform generate therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer (NK) cells. GTB-3550 is the Company's TriKE product candidate, which is a single-chain...
Michael Breen
Executive Chairman of the Board, Interim Chief Executive Officer
Manu Ohri
Chief Financial Officer
Address
8000 MARINA BLVD, SUITE 100
Brisbane, CA
94005
United States

Top Peers

SYMBOLLASTCHG%CHG
SEEL
Seelos Therapeutics Inc
0.63+0.0453+7.75%
SCYX
SCYNEXIS Inc
2.12+0.02+0.95%
INFI
Infinity Pharmaceuticals Inc
0.6266-0.0118-1.8484%
ZYNE
Zynerba Pharmaceuticals Inc
0.959-0.0293-2.9647%
ADMP
Adamis Pharmaceuticals Corp
0.4132-0.0346-7.7267%